Skin2Neuron
- Biotech or pharma, therapeutic R&D
A unique, unipotent autologous cell therapy for Alzheimer. Reversal of memory impairment & 9SD increase in synapses in AD dogs. No pluripotency or gene mods. Closed, automated, reliable CMC. Tier 1 strategic investor. 2y path to FIH. PET readout 6m later
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}